These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 28617550

  • 1. Prognostic and diagnostic significance of long non-coding RNA AGAP2-AS1 levels in patients with non-small cell lung cancer.
    Fan KJ, Liu Y, Yang B, Tian XD, Li CR, Wang B.
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2392-2396. PubMed ID: 28617550
    [Abstract] [Full Text] [Related]

  • 2. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W, Sun M, Zang C, Ma P, He J, Zhang M, Huang Z, Ding Y, Shu Y.
    Cell Death Dis; 2016 May 19; 7(5):e2225. PubMed ID: 27195672
    [Abstract] [Full Text] [Related]

  • 3. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
    Deng J, Liang Y, Liu C, He S, Wang S.
    Biomed Pharmacother; 2015 Oct 19; 75():8-11. PubMed ID: 26463625
    [Abstract] [Full Text] [Related]

  • 4. Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression and poor prognosis in patients with non-small cell lung cancer.
    Zhao QS, Li L, Zhang L, Meng XW, Li LL, Ge XF, Li ZP.
    Eur Rev Med Pharmacol Sci; 2016 Jul 19; 20(14):3031-4. PubMed ID: 27460731
    [Abstract] [Full Text] [Related]

  • 5. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
    Zhong P, Hua H, Chen S, Zhu Z, Xie F.
    Medicine (Baltimore); 2021 Dec 23; 100(51):e28425. PubMed ID: 34941192
    [Abstract] [Full Text] [Related]

  • 6. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
    Li W, Li N, Kang X, Shi K.
    Clin Chim Acta; 2017 Dec 23; 475():152-156. PubMed ID: 29080690
    [Abstract] [Full Text] [Related]

  • 7. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
    Tantai J, Hu D, Yang Y, Geng J.
    Int J Clin Exp Pathol; 2015 Dec 23; 8(7):7887-95. PubMed ID: 26339353
    [Abstract] [Full Text] [Related]

  • 8. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
    Tan J, Yang L.
    Biomed Pharmacother; 2018 Oct 23; 106():1600-1606. PubMed ID: 30119235
    [Abstract] [Full Text] [Related]

  • 9. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
    Tang LX, Su SF, Wan Q, He P, Xhang Y, Cheng XM.
    Eur Rev Med Pharmacol Sci; 2019 Sep 23; 23(17):7419-7429. PubMed ID: 31539129
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
    Qi F, Liu X, Wu H, Yu X, Wei C, Huang X, Ji G, Nie F, Wang K.
    J Hematol Oncol; 2017 Feb 16; 10(1):48. PubMed ID: 28209205
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma.
    Gao L, Zhao A, Wang X.
    Oncol Lett; 2020 Jun 16; 19(6):3993-4001. PubMed ID: 32382344
    [Abstract] [Full Text] [Related]

  • 13. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
    Tao Y, Tang Y, Yang Z, Wu F, Wang L, Yang L, Lei L, Jing Y, Jiang X, Jin H, Bai Y, Zhang L.
    Int J Biol Sci; 2020 Jun 16; 16(3):471-482. PubMed ID: 32015683
    [Abstract] [Full Text] [Related]

  • 14. Long non-coding RNA HNF1A-AS1 up-regulation in non-small cell lung cancer correlates to poor survival.
    Ma YF, Liang T, Li CR, Li YJ, Jin S, Liu Y.
    Eur Rev Med Pharmacol Sci; 2016 Dec 16; 20(23):4858-4863. PubMed ID: 27981551
    [Abstract] [Full Text] [Related]

  • 15. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
    Lv J, Qiu M, Xia W, Liu C, Xu Y, Wang J, Leng X, Huang S, Zhu R, Zhao M, Ji F, Xu L, Xu K, Yin R.
    J Exp Clin Cancer Res; 2016 May 06; 35():75. PubMed ID: 27154193
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW, Wang TB, Tian YH, Zheng YG.
    Int J Clin Exp Pathol; 2015 May 06; 8(11):14983-8. PubMed ID: 26823832
    [Abstract] [Full Text] [Related]

  • 17. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma.
    Gong W, Tian M, Qiu H, Yang Z.
    Cancer Biomark; 2017 Dec 06; 20(4):417-424. PubMed ID: 28946548
    [Abstract] [Full Text] [Related]

  • 18. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
    Wang H, Wang J, Liang CF, Zhou T.
    Clin Lab; 2018 Sep 01; 64(9):1341-1348. PubMed ID: 30274002
    [Abstract] [Full Text] [Related]

  • 19. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer.
    Zhang G, An X, Zhao H, Zhang Q, Zhao H.
    Biomed Pharmacother; 2018 Feb 01; 98():594-599. PubMed ID: 29289833
    [Abstract] [Full Text] [Related]

  • 20. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H, Gao XY, Li P, Jiang TS.
    Tumour Biol; 2015 Mar 01; 36(3):2179-84. PubMed ID: 25412952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.